Record overview
Status and phase
Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2
Sponsor: National Cancer Institute (NCI)
Condition: Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7
NCT01979523
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: primary_completion_date_past_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.